Legal Opinion
General Hospital Corporation v. Sienna Biopharmaceuticals
Court of Appeals for the Federal Circuit
Decided May 4, 2018No. 2017-1012PublishedCited by 8 opinions
1Opinion of the Court
Moore, Circuit Judge.
General Hospital Corp. ("GHC") appeals the Patent Trial and Appeal Board's dismissal of an interference determining it lacked standing because claims of U.S. Patent Application No. 13/789,575 lacked sufficient written description under § 112 of the Patent Act. It further appeals the Board's denial of its contingent motion to add a new claim. We vacate the Board's termination of the interference and remand for further proceedings.
BACKGROUND
The claims at issue relate to methods of removing hair using nanoparticles to damage hair follicles. GHC is the named applicant on the…
2Cases cited14 opinions
- Ariad Pharmaceuticals, Inc. v. Eli Lilly and Co.Court of Appeals for the Federal Circuit · 2010
- Galderma Laboratories, L.P. v. Tolmar, Inc.Court of Appeals for the Federal Circuit · 2013
- In Re Lance G. Peterson and Ioannis VasatisCourt of Appeals for the Federal Circuit · 2003
- Atofina v. Great Lakes Chemical CorporationCourt of Appeals for the Federal Circuit · 2006
- Genetics Institute, LLC v. Novartis Vaccines & Diagnostics, Inc.Court of Appeals for the Federal Circuit · 2011
9 more not listed; retrieve them via the Exa API.
3Cited by8 opinions
- Arthrex, Inc. v. Smith & Nephew, Inc.Court of Appeals for the Federal Circuit · 2022
- Parus Holdings, Inc. v. Google LLCCourt of Appeals for the Federal Circuit · 2023
- Rai Strategic Holdings, Inc. v. Philip Morris Products S.A.Court of Appeals for the Federal Circuit · 2024
- Arthrex, Inc. v. Smith & Nephew, Inc.Court of Appeals for the Federal Circuit · 2022
- Duke University v. Sandoz Inc.Court of Appeals for the Federal Circuit · 2025
3 more not listed; retrieve them via the Exa API.